Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. supplementary table 1 from Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA
  1. Home
  2. Publications
  3. supplementary table 1 from Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA

supplementary table 1 from Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA

Authors:
  • PAPeter Anderson
    Peter Anderson
  • MGMaurizio Ghisoli
    Maurizio Ghisoli
  • BCBrian D. Crompton
    Brian D. Crompton
  • KKKelly S. Klega
    Kelly S. Klega
  • LWLeonard H. Wexler
    Leonard H. Wexler
  • ESEmily K. Slotkin
    Emily K. Slotkin
  • LSLaura Stanbery
    Laura Stanbery
  • LMLuisa Manning
    Luisa Manning
  • GWGladice Wallraven
    Gladice Wallraven
  • MMMeghan Manley
    Meghan Manley
  • SHStaci Horvath
    Staci Horvath
  • EBErnest Bognar
    Ernest Bognar

Open Access
Publisher website
Google Scholar
  • 1 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.22490743
Abstract
No abstract available
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.